EA200001186A1 - Терапевтические комбинации (избирательных) модуляторов рецепторов эстрогенов (имрэ) и стимуляторов секреции гормона роста (ссгр) для лечения скелетно-мышечной слабости - Google Patents

Терапевтические комбинации (избирательных) модуляторов рецепторов эстрогенов (имрэ) и стимуляторов секреции гормона роста (ссгр) для лечения скелетно-мышечной слабости

Info

Publication number
EA200001186A1
EA200001186A1 EA200001186A EA200001186A EA200001186A1 EA 200001186 A1 EA200001186 A1 EA 200001186A1 EA 200001186 A EA200001186 A EA 200001186A EA 200001186 A EA200001186 A EA 200001186A EA 200001186 A1 EA200001186 A1 EA 200001186A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
electional
ssgr
imre
modulators
Prior art date
Application number
EA200001186A
Other languages
English (en)
Russian (ru)
Inventor
Хуа Жу Ки
Мей ЛИ
Лидия Кодетта Пэн
Дейвид Дуйэн Томпсон
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of EA200001186A1 publication Critical patent/EA200001186A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA200001186A 1998-06-16 1999-06-16 Терапевтические комбинации (избирательных) модуляторов рецепторов эстрогенов (имрэ) и стимуляторов секреции гормона роста (ссгр) для лечения скелетно-мышечной слабости EA200001186A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16
PCT/IB1999/001117 WO1999065486A1 (en) 1998-06-16 1999-06-16 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (1)

Publication Number Publication Date
EA200001186A1 true EA200001186A1 (ru) 2001-06-25

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200001186A EA200001186A1 (ru) 1998-06-16 1999-06-16 Терапевтические комбинации (избирательных) модуляторов рецепторов эстрогенов (имрэ) и стимуляторов секреции гормона роста (ссгр) для лечения скелетно-мышечной слабости

Country Status (30)

Country Link
EP (1) EP1087764A1 (sk)
JP (1) JP2002518326A (sk)
KR (1) KR20010052852A (sk)
CN (1) CN1301160A (sk)
AP (1) AP9901582A0 (sk)
AR (1) AR018869A1 (sk)
AU (1) AU4054799A (sk)
BG (1) BG105041A (sk)
BR (1) BR9911324A (sk)
CA (1) CA2335134A1 (sk)
CO (1) CO5070587A1 (sk)
EA (1) EA200001186A1 (sk)
GT (1) GT199900087A (sk)
HN (1) HN1999000097A (sk)
HR (1) HRP20000859A2 (sk)
HU (1) HUP0102505A3 (sk)
ID (1) ID27599A (sk)
IL (1) IL138630A0 (sk)
IS (1) IS5691A (sk)
MA (1) MA26652A1 (sk)
NO (1) NO20006312D0 (sk)
OA (1) OA11505A (sk)
PA (1) PA8475901A1 (sk)
PE (1) PE20000646A1 (sk)
PL (1) PL344981A1 (sk)
SK (1) SK18912000A3 (sk)
TN (1) TNSN99124A1 (sk)
TR (1) TR200003544T2 (sk)
WO (1) WO1999065486A1 (sk)
ZA (1) ZA993975B (sk)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047735A2 (en) * 1999-02-08 2000-08-17 Mcgill University NON-HUMAN TRANSGENIC ANIMAL WHOSE GERM CELLS AND SOMATIC CELLS CONTAIN A KNOCKOUT MUTATION IN DNA ENCODING ORPHAN NUCLEAR RECEPTOR ERRalpha
ES2274854T3 (es) 2000-05-08 2007-06-01 Pfizer Products Inc. Resolucion enzimatica de moduladores selectivos del receptor de estrogeno.
CA2420535A1 (en) 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
ES2604943T3 (es) 2007-02-09 2017-03-10 Ocera Therapeutics, Inc. Moduladores macrocíclicos del receptor de la grelina y procedimientos de uso de los mismos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
PE20000646A1 (es) 2000-08-05
TNSN99124A1 (fr) 2005-11-10
HUP0102505A3 (en) 2002-12-28
AR018869A1 (es) 2001-12-12
ID27599A (id) 2001-04-12
CA2335134A1 (en) 1999-12-23
ZA993975B (en) 2000-12-15
AP9901582A0 (en) 1999-06-30
NO20006312L (no) 2000-12-12
KR20010052852A (ko) 2001-06-25
HN1999000097A (es) 1999-11-03
PA8475901A1 (es) 2000-05-24
EP1087764A1 (en) 2001-04-04
CN1301160A (zh) 2001-06-27
BG105041A (en) 2001-08-31
NO20006312D0 (no) 2000-12-12
HRP20000859A2 (en) 2001-04-30
IS5691A (is) 2000-10-27
CO5070587A1 (es) 2001-08-28
WO1999065486A1 (en) 1999-12-23
OA11505A (en) 2004-05-07
AU4054799A (en) 2000-01-05
HUP0102505A2 (hu) 2001-11-28
IL138630A0 (en) 2001-10-31
TR200003544T2 (tr) 2001-04-20
JP2002518326A (ja) 2002-06-25
MA26652A1 (fr) 2004-12-20
PL344981A1 (en) 2001-11-19
BR9911324A (pt) 2001-04-03
SK18912000A3 (sk) 2001-10-08
GT199900087A (es) 2000-12-07

Similar Documents

Publication Publication Date Title
DE60037836D1 (de) ThiazoloÄ4,5-dÜpyrimidinverbindungen zur Behandlung von rheumathoider Arthritis
EA200000298A1 (ru) Агонисты простагландинов и их применение для лечения заболеваний костей
IL165262A (en) Kinase inhibitors and pharmaceutical compositions containing them
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
NO20052219D0 (no) Fremgangsmater for behandling av postkirurgisk smerte ved administrering av en nervevekstfaktorantagonist og preparater inneholdende dette
NO990663L (no) Substituerte pyrimidinderivater og deres farmas°ytiske anvendelse
EA200001186A1 (ru) Терапевтические комбинации (избирательных) модуляторов рецепторов эстрогенов (имрэ) и стимуляторов секреции гормона роста (ссгр) для лечения скелетно-мышечной слабости
AP9901580A0 (en) Therapeutic combination comprising a selective estrogen receptor modulator and parathyroid hormone.
EA200001189A1 (ru) Терапевтические комбинации (избирательных) модуляторов рецепторов эстрогенов (имрэ) и стимуляторов секреции гормона роста (ссгр) для лечения скелетно-мышечной слабости
NZ504051A (en) Crystalline polymorphs of 1,3-di-cyclopropylmethyl-8-amino xanthine (cypamfylline), and the use of these compounds for treating PDE4 or TNF mediated diseases
YU60803A (sh) Upotreba antagonista gal3 receptora u lečenju depresije i/ili uznemirenosti i jedinjenja korisna u tim postupcima
MXPA01007952A (es) Formulaciones a base de l-arginina para tratar enfermedades, y metodos para usarlas.
DE69916932D1 (de) Kombinationstherapeutika, enthaltend einen selektiven Östrogenrezeptormodulator und Prostaglandin E2
ECSP993021A (es) Combinaciones terapeuticas para la fragilidad musculoesqueletica
ECSP993020A (es) Terapia de combinacion para la fragilidad musculoesqueletica
TH57984A3 (th) การรวมในทางการรักษาซี่งประกอบด้วยตัวปรับตัวรับเอสโตรเจนแบบคัดเลือกและฮอร์โมนพาราไธรอยด์